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Background: Understanding the topology and dynamics of the human protein-protein interaction (PPI) network
will significantly contribute to biomedical research, therefore its systematic reconstruction is required. Several meta-
databases integrate source PPI datasets, but the protein node sets of their networks vary depending on the PPI
data combined. Due to this inherent heterogeneity, the way in which the human PPI network expands via multiple
dataset integration has not been comprehensively analyzed. We aim at assembling the human interactome in a
global structured way and exploring it to gain insights of biological relevance.
Results: First, we defined the UniProtKB manually reviewed human “complete” proteome as the reference protein-
node set and then we mined five major source PPI datasets for direct PPIs exclusively between the reference
proteins. We updated the protein and publication identifiers and normalized all PPIs to the UniProt identifier level.
The reconstructed interactome covers approximately 60% of the human proteome and has a scale-free structure.
No apparent differentiating gene functional classification characteristics were identified for the unrepresented
proteins. The source dataset integration augments the network mainly in PPIs. Polyubiquitin emerged as the
highest-degree node, but the inclusion of most of its identified PPIs may be reconsidered. The high number (>300)
of connections of the subsequent fifteen proteins correlates well with their essential biological role. According to
the power-law network structure, the unrepresented proteins should mainly have up to four connections with
equally poorly-connected interactors.
Conclusions: Reconstructing the human interactome based on the a priori definition of the protein nodes enabled
us to identify the currently included part of the human “complete” proteome, and discuss the role of the proteins
within the network topology with respect to their function. As the network expansion has to comply with the
scale-free theory, we suggest that the core of the human interactome has essentially emerged. Thus, it could be
employed in systems biology and biomedical research, despite the considerable number of currently unrepresented
proteins. The latter are probably involved in specialized physiological conditions, justifying the scarcity of related PPI
information, and their identification can assist in designing relevant functional experiments and targeted text
mining algorithms.
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Deciphering the structure and dynamics of the protein-
protein interaction (PPI) networks is among the major
objectives of the systems biology research in the quest
for the mechanisms of life. For the human protein
interactome in particular, its reconstruction and further
exploration of its topology and dynamics are expected to
have a significant impact in biomedical research and
applications [1,2]. The number of experimentally sup-
ported PPIs has drastically increased for model organ-
isms since 2000 [3-7] and for the human interactome
since 2005 [8,9] mainly due to the gradually increasing
number of high-throughput methodologies for PPI de-
tection. The experimentally identified PPIs are mined
from the literature and stored in bulk in PPI databases,
most of which are repositories for many species. For the
human interactome, the various source PPI databases re-
port the protein identifiers at different molecular levels
of biological information, and include protein interaction
sets of limited overlap due to own literature mining
criteria, differences in PPI incorporation rates from small-
scale experiments, as well as differences in methods for PPI
selection, curation and updating [10-14]. Therefore, several
PPI meta-databases also exist, combining information from
multiple source databases [15-23]. However, as each meta-
database has distinct curation objectives and methods for
data normalization and integration, the use of its combined
PPI dataset may not be straight away comparable to the dir-
ect query on the source databases [11,12]. In addition, it is
worth mentioning that the set of protein nodes of a meta-
database network varies depending on the PPIs of the
employed source datasets, and it may change upon updat-
ing or incorporation of new datasets. This fact creates het-
erogeneity between the various PPI meta-databases and
hinders the direct comparison among their networks [11].
Because of this inherent heterogeneity, although there have
been many studies comparing a variety of PPI datasets
[10-14], the way in which the human protein interactome
expands via the integration of multiple datasets has not
been comprehensively explored; therefore, a global perspec-
tive of the biology emerging from the network structure is
still eluding.
The objective of the present study is to reconstruct
the current experimentally supported network of direct
human protein interactions in a global structured way,
explore it to obtain information about the fraction of the
human proteome that it currently involves, discuss the
biological role of proteins within the topology of the net-
work, and identify the presently absent from the network
(“orphan”) proteins. To this end, we started by defining
the UniProtKB manually reviewed human “complete”
proteome [24] as the reference set of nodes that the hu-
man PPI network can have. Then, we mined five major
source PPI databases, i.e.: HPRD [25], IntAct [26],MINT [27], DIP [28] and BioGRID [29], for direct inter-
actions exclusively between members of the defined
reference protein set. After appropriate updating of the
old and filtering of the obsolete protein identifiers, the
acquired PPI data were normalized to and combined at
the UniProt protein identifier level. We analyzed the
reconstructed network to discuss whether the revealed
role of proteins based on their position in the
interactome topology is supported by the currently
available knowledge about their function. In addition,
based on the verified scale-free structure of the PPI
network in human [1,30], we predict the number of
connections of the unrepresented proteins and provide
a novel perspective about the presently “missing” part
of the interactome.
Methods
Protein and PPI datasets
The UniProtKB/Swiss-Prot manually reviewed human
“complete” proteome
From UniProtKB, the knowledgebase of the Universal
Protein (UniProt) resource [24], we downloaded the
tab-delimited files of: (a) the entire set of human
UniProt identifiers, and (b) the manually reviewed hu-
man “complete” proteome. The latter contained 20,242
UniProt identifiers in the Dec 14 2011 release of
UniProtKB downloaded on Jan 23 2012. The two tab-
delimited files included all default columns augmented
by the cross-references with the EMBL nucleotide, the
NCBI nucleotide and the Entrez Gene databases. The
text file indicating the correspondence of the second-
ary to the respective primary UniProt identifier(s) was
downloaded too.
The Human Protein Reference Database (HPRD)
HPRD is a manually curated reference database for hu-
man protein information [25]. In this study, we used
only its binary PPI dataset, which is provided in the form
of interactions between HPRD identifiers. From the
total 19651 HPRD identifiers in the HPRD version 9,
downloaded on Jan 23 2012, 9673 were involved in at
least one of the 39204 PPIs reported as binary interac-
tions. Only the primary one-to-one correspondence of
the HPRD identifiers to nucleotide sequence identifiers
was considered. Any necessary updating or conversion
of the nucleotide sequence identifiers to other molecular
levels of biological information (i.e. gene or protein
level) was carried out through cross-reference with
current versions of the relevant databases.
IntAct
IntAct, a main partner of the International Molecular
Exchange (IMEx) Consortium [10], is a repository of
molecular interaction data for multiple organisms [26].
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cluding interaction information from all species, PPIs
are provided mainly at the UniProt protein identifier
level. From the Jan 3, 2012 release downloaded on Jan
30, 2012, only the non - “spoke” PPIs between two hu-
man protein identifiers were retained, as the label
“spoke” characterizes the PPIs originated from protein
complex expansion.The Molecular INTeraction database (MINT)
Similarly to IntAct, MINT [27] is a repository of literature-
curated PPIs from multiple organisms and an IMEx consor-
tium partner with PPI information provided mainly at the
UniProt protein identifier level. The binary PPI file for
human used in the present study was downloaded on Jan
30, 2012 (release date: Dec 8, 2011).Database of Interacting Proteins (DIP)
DIP [28] is also a collection of experimentally supported
protein interactions from multiple organisms and among
the first partners of the IMEx consortium. In the
downloaded on Jan 30, 2012 PPI file for human (release
date: Oct 27 2011), PPIs are provided as interactions be-
tween DIP identifiers. The latter are corresponded
mainly to UniProt protein identifier(s) and most to
NCBI nucleotide RefSeq identifier(s), too.The Biological General Repository for Interaction Datasets
(BioGRID)
BioGRID [29] is the most recently initiated among the
five source PPI databases used in this study, currently
participating in the IMEx consortium as an affiliate
member. The PPI file for human was downloaded from
the BioGRID web site on Jan 30, 2012 (release 3.1.84
tab2 file). PPIs are provided as interactions between
BioGRID identifiers, which are in one to one corres-
pondence to Entrez Gene identifiers (GeneID). BioGRID
provides extensive information about the experimental
method and the nature, i.e. low- or high- throughput, of
the experimental set-up used for any PPI detection;
however, it does neither make a distinction between
binary interaction and protein complex data nor provide
a relevant filtering criterion. To avoid including PPI
data expanded from protein complexes, we opted to
keep (a) all physical associations identified in low-
throughput setups and (b) from the physical associa-
tions detected only in high-throughput experiments,
those derived from any of “protein complementation
assay (PCA)”, “reconstituted complex”, “protein-pep-
tide”, “FRET”, “two-hybrid” or “co-crystal structure”
methods. Genetic interactions provided in BioGRID
were de facto filtered out.PPI data mining
Direct PPIs with both interactors belonging to the set of
the 20,242 primary UniProt identifiers included in the
manually reviewed human “complete” proteome were
mined from: (a) the binary PPI dataset of HPRD, (b) all
PPIs of IntAct not characterized with the term “spoke” in
the “expansion” field, (c) the binary PPI dataset of MINT,
(d) the DIP dataset, which is provided as containing
only binary manually reviewed PPIs, and (e) all phys-
ical associations in BioGRID detected in at least one
low-throughput experiment or by any of the detection
methods mentioned above, if identified only in high-
throughput setups.
Protein identifier normalization
Normalization of the protein identifiers to the UniProt
identifier level was required for: (a) HPRD, since it re-
ports the interactors at the nucleotide sequence level,
(b) BioGRID, which reports the interactors at the gene level
and (c) few cases of IntAct, MINT and DIP, for which other
than the default UniProt identifier has been used.
Source PPI dataset uploading
To upload, store and handle the five PPI datasets and in-
tegrate them into the final reconstructed PPI network,
the Microsoft SQL Server (MSSQL) 2008 Developer
Edition platform equipped with SQL Server Integration
Services (SSIS) was used under the University of Patras
academic license. The source PPI dataset uploading was
organized in a set of SSIS modules executed at the ser-
ver side. Each module involves a series of subtasks for
the filtering and updating of certain data from the
source PPI dataset, along with a large number of checks
to monitor and handle exceptions, avoiding thus the
contamination of the final database with erroneous or
ill-formatted data. Additional file 1 shows the workflow
for the IntAct uploading sub-module.
The first subtask of the filtering and updating algo-
rithm involves the extraction of the interactions between
human protein identifiers. In sequence, the main
interactor identifiers are retained for each PPI. For In-
tAct, MINT and DIP, the interactors are expected to be
represented by a UniProtKB accession number. If the
relevant format is not recovered from the algorithm for
any of the two interactors, then the non-UniProt
interactor identifier is compared against a maintained
interactor identifier dictionary. If matched to a diction-
ary entry and identified as active, the non-UniProt
interactor identifier is replaced by the corresponding
primary UniProt identifier. If it has become obsolete or
cannot be assigned to a UniProtKB accession number,
it is removed from the finally uploaded dataset along
with all associated PPIs. If active, all isoform UniProt
protein identifiers are replaced by their primary UniProt
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fiers are stored in a separate table, for the curator to appro-
priately update the interactor identifier dictionary, so that
the “patching” process is completed in a second iteration.
In HPRD, the interactor identifier dictionary is used to up-
date the nucleotide sequence identifiers to their currently
active entries. Notably, among the 9673 HPRD identifiers
involved in PPIs, 119 were identified to correspond to obso-
lete nucleotide sequence identifiers, 4 corresponded to non
protein-coding RNAs, while 16 were replaced by new nu-
cleotide sequence identifiers; due to this updating, in three
cases, two HPRD identifiers were assigned to the same nu-
cleotide sequence identifier. In BioGRID, all interactors
were identified by an active Entrez GeneID, thus no updat-
ing was necessary. For the PPIs remaining after the
interactor identifier patching step, the algorithm inspects
the identifier of the supporting publication(s). If no publica-
tion is provided, the PPI is removed from the uploaded
dataset. If a non-PubMed publication identifier
is provided, this is patched based on an in-memory
maintained dictionary as described for the interactor identi-
fiers in the previous step. The utilized interactor identifier
dictionary was created based on information recovered
from the online UniProt converter and the online versions
of all relevant databases on February 2, 2012. The Digital
Object Identifier (DOI) numbers and IMEx reference iden-
tifiers were assigned to their PubMed publication identifiers
based on an online converter and the online version of
MINT, respectively. After uploading IntAct, MINT and
DIP, their PPI data were further processed based on infor-
mation from UniProtKB to include only interactions be-
tween two active primary UniProt identifiers in the human
manually reviewed “complete” proteome.
Gene functional classification analysis
Gene functional classification analysis was carried out
using the DAVID Bioinformatics Resources version 6.7
[31,32] by combining all available gene annotation
categorizations.
Identification of network characteristics
The identification of the reconstructed PPI network
characteristics was carried out using the relevant
“Network Analysis” tool of the open source network
visualization and analysis software Cytoscape - version
2.8 [33].
Results and discussion
Reconstructing the human protein interactome based on
a well-defined set of protein nodes
The novelty of our approach regarding the PPI data inte-
gration from major literature-curated source PPI
datasets compared to existing meta-databases was the a
priori definition of the set of nodes of the human proteininteractome considering the UniProtKB manually
reviewed human “complete” proteome as a robust,
well-defined reference set. Thus, instead of merging
PPI information for any protein identifier stored in the
source databases, the latter were selectively mined for
PPIs exclusively between members of the as above
defined reference human protein set.
For proper normalization of the source PPI datasets to
the UniProt identifier level, it was also important to con-
sider the continuous updating of biological information,
since it can lead to changes in the annotation of protein
identifiers and in their associations at other molecular
levels. Thus, we proceeded to a careful updating of the
old and filtering of the obsolete protein identifiers in the
source datasets based on the current knowledge about
gene annotation. UniProtKB and its cross-references
with major resources at the nucleotide sequence and
gene levels of molecular information (i.e. NCBI, Entrez
Gene and EMBL databases) provided a valuable refer-
ence for the appropriate normalization of HPRD and
BioGRID identifiers to the UniProt level, and of a small
fraction of IntAct, MINT and DIP protein entries that
were not provided at the default UniProt level. It is
noted that during this conversion to the UniProt level,
1920 BioGRID identifiers reported as human were found
to correspond to non-human UniProt identifiers (data
not shown), leading thus to the exclusion of their PPIs
from the final integrated PPI network.
In the normalized HPRD, IntAct, MINT, DIP and
BioGRID files, only the PPIs between two active primary
UniProt identifiers in the manually reviewed human
“complete” proteome were retained. These datasets were
combined keeping one record for each included PPI. A
last source of PPI redundancy in the normalized datasets
that was eliminated, concerns the double reporting of
an interaction using opposite sequence of the two
interactors. In some cases, such duplications may have
been intentionally included by the curator of a source
PPI dataset to report the experimentally supported se-
quence of the interactors; this type of duplications were
encountered in IntAct and MINT. In most cases, how-
ever, they were just a product of the protein identifier
conversions at the various stages of the PPI dataset
uploading and formatting and had to be eliminated at
the integration stage.
The final integrated PPI dataset will be referred to as
the PICKLE (Protein InteraCtion KnowLedge BasE)
dataset. Table 1 shows the number of (a) the direct PPIs
in the PICKLE and the normalized source PPI datasets,
(b) the UniProt identifiers in the manually reviewed hu-
man “complete” proteome covered by each of them, and
(c) the publications providing experimental evidence for
the PPIs. As expected, the integrated PICKLE dataset is
much larger than any of the individual source datasets







Mean Number of PPIs per
Publication (x/y)
UniProtKB manually reviewed human
“complete” proteome
20242 N/A N/A N/A
HPRD 9303 37152 19267 1.93
IntAct 6666 19425 1598 12.15
MINT 6102 16147 2398 6.73
DIP 1795 2609 1180 2.21
BioGRID 9265 42647 13818 3.08
PICKLE 11827 75965 26689 2.85
The size of the reconstructed network is compared to the size of the normalized to the UniProt identifier level source PPI datasets for the defined reference
protein set. N/A: not applicable.
(1)members of the UniProtKB manually reviewed human “complete” proteome.
(2)between members of the UniProtKB manually reviewed human “complete” proteome.
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interactors and of the supporting publications, verifying
the value of PPI resource integration.
Reconstructing the PPI network in this global struc-
tured way:
 we resolve the issue of potential protein identifier
and consequently PPI redundancy in the network
originating from the combination of records of
multiple databases reporting at different levels of
biological information;
 we determine which protein nodes of the manually
reviewed human “complete” proteome remain with
no direct PPIs (“orphan” proteins) and discuss this
fact in the context of the current information about
these proteins;
 we comment on the proteins represented in the
interactome with a high number of PPIs with
respect to the importance of their function within
the entire network;
 we consider the human interactome in its entirety,
commenting on its future expansion to the maximum
potential format in the context of the expected scale-
free structure, a fundamental feature of PPI networks
[30,34]. Consequently, the interactome reconstructed
in the presented way can only grow in edges (PPIs)
between the defined set of protein nodes, while keeping
its scale-free form. In this global context, we can argue
for the expected number of interactions for the
“orphan” protein nodes and for the type of their
interactors, suggesting a novel perspective for the
currently “missing” part of the network, as it is
discussed in the following sections.
The reconstructed interactome covers nearly 60% of the
manually reviewed human “complete” proteome
Out of the 20,242 UniProt identifiers in the manually
reviewed human “complete” proteome, 11827 (58.4%)were found to have a total number of 75965 direct inter-
actions (Table 1). Gene functional classification analysis
(see Methods section) of the proteins currently included
in the reconstructed interactome compared to the “or-
phan” ones did not indicate any functional annotations
that could differentiate the one group from the other.
Thus, the presently “orphan” proteins are not associated
with any apparent functional or subcellular location
characteristics that could “hinder” them from binding
with other proteins.
Dataset integration augments the overall network mainly
with additional interactions for largely overlapping sets
of proteins
HPRD and BioGRID are the main contributors of the
overall human PPI network, comprising, respectively,
78.7% and 78.3% of its UniProt identifiers, and 48.9%
and 56.1% of its PPIs (Table 1 and Figures 1, 2 and 3).
Moreover, exclusion of the information from HPRD and
BioGRID wοuld, respectively, decrease the overall net-
work by 20.4% and 18.9% in proteins and 33.2% and
39.1% in PPIs. These characteristics can be partially jus-
tified by the number of references used by each of these
two databases, constituting 72.2% (HPRD) and 51.8%
(BioGRID) of the total number of supporting references.
In addition, HPRD is one of the first literature-curated
databases, having though a decline in the rate of refer-
ence (and thus PPI) incorporation after 2005 (Figure 3B).
BioGRID is currently the fastest growing, having also in-
corporated a significant part of the HPRD PPI network
at the time of its creation [11,29]. This information
complements the observed much higher curation over-
lap between HPRD and BioGRID compared to the other
pairs of source PPI datasets discussed by Turinsky et al.
in [12]. On the other hand, IntAct corresponds to the
largest ratio of PPIs per number of references, i.e. 12.1,
followed by MINT, i.e. 6.7 (Table 1), indicating that
a major fraction of their datasets originates from
Figure 1 Source of data in the integrated PICKLE PPI dataset.
(A) UNIPROT_IDs (B) PPIs
Figure 2 The fractions of PICKLE UniProt identifiers (A) and PPIs (B) contributed from combinations of source datasets. The common
contributions for the nodes and the edges of the integrated PPI network from all five source datasets constitute 8.7% and 0.2% of the total,
respectively. Only the values of the larger than 3% fractions are shown with the exception of the unique contributions from each individual
source dataset, for which all fractions are indicated.
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Figure 3 The PICKLE reference fraction contributed from source datasets (A) and the reference incorporation rate in the datasets (B).
Only 8 common references between the five datasets were identified, confirming that they incorporate knowledge from different studies. In (A),
only the values of the larger than 3% fractions are shown with the exception of the unique contributions from each individual source dataset, for
which all fractions are indicated.
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the reconstructed human protein interactome is mainly
supported by small-scale studies (Figure 4A); 91% of the
references supporting the PICKLE PPI dataset refer to a
maximum of five PPIs, and only 51 publications report
more than 100 PPIs. In this aspect, PICKLE follows the
characteristics of HPRD, currently the main contributor
of references to the overall dataset. It is worth
mentioning that 84% of the 75965 PPIs in the human
interactome are supported by only one reference
(Figure 4B) and just 42 PPIs by more than 20
(Additional file 2). Considering that the degree of confi-
dence of a given PPI increases with the number of inde-
pendent supporting references [35], it is evident that,
apart from exploiting existing models for PPI assessment
[36], further targeted experimentation is required for
validating the majority of the PPI data.
A noteworthy observation of our work, revealing an
interesting aspect of the literature-supported PPI data
collections, is that the fraction of protein nodes that
each source dataset uniquely contributes to the inte-
grated network is much smaller than the corresponding
fraction for the PPIs, even for the largest HPRD and
BioGRID datasets (Figures 1 and 2). The PPI diversity
between the source datasets has been discussed earlier
[e.g. 10, 12] and mainly attributed to the fact that the
various databases incorporate knowledge from differentpublications. This was recently presented for the IMEx
Consortium member databases [10] and validated in the
present study from the substantially small number, i.e.
eight, of common references between the five employed
datasets (Figure 1). Furthermore, Turinsky et al. [12]
showed that the source databases exploit different cur-
ation criteria even for the shared publications. Thus, it is
striking that, despite the heterogeneous text mining and
data curation methods used by the various databases,
the integration of multiple source PPI datasets augments
mainly the interactome with different PPIs for essentially
the same part of the manually reviewed human “complete”
proteome.
This observation suggests that the knowledge about
direct PPIs that is available in the literature and can be
promptly identified through existing text mining algo-
rithms refers mainly to the fraction, i.e. approximately
60%, of the manually reviewed human “complete” prote-
ome already incorporated in the interactome, while
evidence for PPIs for the rest 40% cannot be easily
spotted. In this context, as PPI information from all
high-throughput experiments has been included in at
least one of the source datasets, there are two possibil-
ities for the “orphan” proteins: either there is currently
no available PPI information in the literature, or, if
existing, it should concern reports of targeted small-































































































Figure 4 Distribution of PPIs per reference (A) and supporting references per PPI (B) in PICKLE.
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thus advanced directed text mining algorithms. Further-
more, there is a higher probability for such experiments
to refer to PPIs occurring under specialized and/or
highly transient or rare physiological conditions, while
this type of interactions cannot be easily identified in
high-throughput experiments. These implied direct
interaction characteristics for the “orphan” proteins sup-
port a peripheral role for most of them within the top-
ology of the PPI network. In this context, the actual
determination of the “orphan” proteins may assist in di-
rected literature mining to extract potentially existing
relevant PPI information from currently unexploited re-
ports or promote further experimentation to verify the
argument.Τhe proteins with a high number of interactions are
involved in essential biological processes
Analysis of the integrated human PPI network characteris-
tics indicated that 11577 out of the 11827 UniProt identi-
fiers are connected in one component. The remaining 250
proteins are currently in separate components of up to four
nodes, among which 114 homodimers and 46 heterodimers
(Table 2). The vastest functional categories for these pro-
teins as indicated by gene functional classification analysis










174 (i.e.: 1 cluster of 11577 nodes, 114 homodimers,
46 heterodimers,13 isolated of 3 or 4 nodes)
Number of self-loops 2715 (i.e.: 2601 nodes having interactions with



















(1)Detailed description for every characteristic can be found in http://med.
bioinf.mpi-inf.mpg.de/netanalyzer/help/2.6.1/index.html.
(2)Determined using the network analysis tool of Cytoscape (2.8.2).and 89 signal peptides, among which 65 glycoproteins; 68
of the signal peptides, including 39 glycoproteins, are asso-
ciated with extracellular matrix. While the network diam-
eter, i.e. the greatest distance between two protein nodes,
was determined equal to 12, the characteristic path length
is 3.69. This feature along with the equal to 1 radius and
the high value of shortest paths metric (i.e. 95%) indicates a
well-connected network, despite its low density (i.e. 0.001)
(Table 2). The distribution of PPIs per protein, i.e. protein
degree, indicated 53% of the proteins as having up to five
interactions (Figure 5), while 16 UniProt identifiers had
more than 300 PPIs each (Table 3). This pattern is consist-
ent with the relevant “network biology” theory supported
by Barabasi [30,37], according to which the human PPI net-
work is expected to follow a scale-free structure with few
protein hubs and the majority of the protein nodes having a
small number of interactions. Indeed, even though it is cur-
rently incomplete and many interactions are still in need of
verification, the reconstructed human protein interactome
correlates well with the power law (Figure 5), implying that
the degree distribution of the current PPI network already
suggests the role of most proteins as high-, middle- or low-
degree nodes.
The sixteen proteins determined with more than 300
PPIs (Table 3) are mainly implicated in the regulation of
apoptosis (10 proteins), the MAP kinase signalling path-
way (6 proteins) and the cell cycle (7 proteins). A full list
of the most significant protein ontology clusters for
these high-degree proteins is shown in Additional file 3.
Notably, eight of them have been associated with path-
ways in cancer, while subsets of nine are involved in
transcription regulation, covalent chromatin modifica-
tion or the ubiquitin-like modifier (ubl) conjugation
pathway. This information indicates that the observed
central role of these proteins within the topology of the
PPI network is not a mere result of them being exten-
sively studied, i.e. “study bias”, but correlates well with
the current knowledge about their function, as it has
also been suggested earlier for the cancer-associated pro-
teins [38,39]. An additional fact which counter argues
the “study bias” for these proteins is that, apart from
various targeted small-scale experiments, many of their
direct interactions have also been detected in independ-
ent high-throughput setups. For example, at least 54 in-
teractions of the cellular tumor antigen p53 [8,40], 257
interactions of the 14-3-3 protein zeta/delta [41], 212 in-
teractions of the Myc proto-oncogene protein [42] and
48 interactions of the TNF receptor-associated factor 6
[43] have been identified in high-throughput studies.
Polyubiquitin: a hub to be discussed
Polyubiquitin (UniProt identifier: P0CG48, UBC) was
the protein identified with the largest number of interac-
tions in the reconstructed network. It interacts with




(on logarithmized values) = 91.2%























Figure 5 The distribution of direct interactions for the UniProt identifiers in the PICKLE network. The red line indicates the power-law fit
(logarithmic scale); the related equation and R2 correlation are also shown. UniProt identifier P0CG48 (Polyubiquitin, UBC) is identified with the
largest number of interactions, i.e. 1112; note the deviation of this UniProt identifier degree from the power-law fit.
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ally reviewed human “complete” proteome, while the
second ranked high-degree node, i.e.: TP53 (UniProt
identifier: P04637), has 476 interactions. Notably, this
much larger number of interactions for polyubiquitin
compared to the other protein hubs deviates from the
scale-free network structure, assigning a centralized role
to a single protein (Figure 5). Querying the PICKLE
dataset, we identified HPRD, IntAct, MINT, DIP and
BioGRID reporting, respectively, 19 (2 unique), 5 (0
unique), 143 (48 unique), 53 (15 unique) and 1423 (909
unique) polyubiquitin PPIs. Without exhausting our
search regarding polyubiquitin PPI supporting publica-
tions, we detected that our integrated dataset contains
interactions from studies investigating polyubiquitin
function in the context of protein degradation (e.g. [44]).
Polyubiquitin can be covalently linked to a protein
through an isopeptide bond and mark it for degradation
at the proteasome. However, it is questionable whether
this one-sided polyubiquitin action on a protein should
be included in the interactome or should be considered
in the post-translational modification (PTM) network
[45,46]. The latter could explain why, apart from
BioGRID, the other source databases used in this work
have considered a limited number of polyubiquitin PPIs.
In the context of the non-directional PPI network, the
existence of an interaction link from one protein to an-
other directly implies a link in the opposite direction,
too. Consequently, the absence of a protein and thus its
interactions will affect its neighbours and add a certain
stress to the network, the extent of which depends onthe network structure and dynamics. In the case of uni-
directional polyubiquitination of a protein for leading it
to degradation, the absence of the protein will neither
affect polyubiquitin nor exert a stress to the rest of the
polyubiquitin substrates. Thus, this type of actions of a
protein on another should be considered as a separate
category than the non-directional protein-protein in-
teractions and modelled differently for their role in
cell physiology dynamics. On the other hand, the
monoubiquitination of proteins for regulatory pur-
poses (e.g. [47]) fits into the notion of the non-
directional PPI network. However, even in this case, it
is questionable whether ubiquitin itself or rather the
ubiquitinated proteins should be included as nodes of
the network. In this context, the incorporation of
ubiquitin PPIs in the interactome should be cautiously
curated. Accordingly, this argument is also relevant to
other proteins involved in interactions of similar type,
like the small ubiquitin-related modifiers (SUMO1-4)
and neddylin (NEDD8) engaged in the sumoylation
and neddylation reactions, respectively.
The bulk of the proteins currently absent from the
network should have up to four interactions
As shown, the reconstructed human protein
interactome follows the scale-free structure with a
very good correlation (Figure 5). The part of the net-
work that contributes to the decrease in the correl-
ation coefficient refers to the proteins with up to
four interactions. The difference between the data
and the power-law curve for a nearly perfect fit is







Protein Name(s) (based on UniProt Naming Convention) No of PPIs
(Degree)
P0CG48 UBC_HUMAN UBC Polyubiquitin-C [Cleaved into: Ubiquitin] 1112
P04637 P53_HUMAN TP53 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53)
(Tumor suppressor p53)
476
P63104 1433Z_HUMAN YWHAZ 14-3-3 protein zeta/delta (Protein kinase C inhibitor protein 1) (KCIP-1) 471
P01106 MYC_HUMAN MYC Myc proto-oncogene protein (Class E basic helix-loop-helix protein 39) (bHLHe39)
(Proto-oncogene c-Myc) (Transcription factor p64)
453
Q9Y4K3 TRAF6_HUMAN TRAF6 TNF receptor-associated factor 6 (EC 6.3.2.-) (E3 ubiquitin-protein ligase TRAF6)
(Interleukin-1 signal transducer) (RING finger protein 85)
424
Q13547 HDAC1_HUMAN HDAC1 Histone deacetylase 1 (HD1) (EC 3.5.1.98) 353
P12931 SRC_HUMAN SRC Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src)
(pp60c-src) (p60-Src)
351
P62993 GRB2_HUMAN GRB2 Growth factor receptor-bound protein 2 (Adapter protein GRB2) (Protein Ash) (SH2/SH3
adapter GRB2)
341
Q14164 IKKE_HUMAN IKBKE Inhibitor of nuclear factor kappa-B kinase subunit epsilon (I-kappa-B kinase epsilon) (IKK-E)
(IKK-epsilon) (IkBKE) (EC 2.7.11.10) (Inducible I kappa-B kinase) (IKK-i)
338
P61981 1433G_HUMAN YWHAG 14-3-3 protein gamma (Protein kinase C inhibitor protein 1) (KCIP-1) [Cleaved into: 14-3-3
protein gamma, N-terminally processed]
335
Q09472 EP300_HUMAN EP300 Histone acetyltransferase p300 (p300 HAT) (EC 2.3.1.48) (E1A-associated protein p300) 331
Q9UQL6 HDAC5_HUMAN HDAC5 Histone deacetylase 5 (HD5) (EC 3.5.1.98) (Antigen NY-CO-9) 324
P00533 EGFR_HUMAN EGFR Epidermal growth factor receptor (EC 2.7.10.1) (Proto-oncogene c-ErbB-1) (Receptor
tyrosine-protein kinase erbB-1)
313
P03372 ESR1_HUMAN ESR1 Estrogen receptor (ER) (ER-alpha) (Estradiol receptor) (Nuclear receptor subfamily 3 group A
member 1)
312
P27348 1433T_HUMAN YWHAQ 14-3-3 protein theta (14-3-3 protein T-cell) (14-3-3 protein tau) (Protein HS1) 311
Q9Y6K9 NEMO_HUMAN IKBKG NF-kappa-B essential modulator (NEMO) (FIP-3) (IkB kinase-associated protein 1) (IKKAP1)
(Inhibitor of nuclear factor kappa-B kinase subunit gamma) (I-kappa-B kinase subunit
gamma) (IKK-gamma) (IKKG) (IkB kinase subunit gamma) (NF-kappa-B essential modifier)
304
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http://www.biomedcentral.com/1752-0509/7/96calculated to be about 8300 UniProt identifiers, with
more than 6500 of them corresponding to degree
equal to 1. Consequently, with 8415 UniProt identi-
fiers not currently included in the interactome (“or-
phan” proteins), it could be speculated that the vast
majority of them should have up to four interactions
with nodes in the same degree group. This antici-
pated network structure implies that the core of the
human protein interactome has essentially been re-
vealed and could provide a reasonable explanation
for the current lack of PPI information for about
40% of the human proteome, agreeing with a spe-
cialized “peripheral” role for most of these “orphan”
proteins. Indeed, with most of them expected to
have a single PPI, and in general no more than four,
with similarly not well-connected proteins, the prob-
ability of them being involved in specialized physio-
logical conditions is high. This speculation further
corroborates with the fact that interactions for these
proteins cannot be easily confirmed in PPI identifica-
tion experiments, as discussed in section C.Conclusions
We have obtained a normalized and clean from out-
dated protein identifier annotations integrated set of
direct PPIs referring to the well-defined UniProtKB
manually reviewed human “complete” proteome. We
suggest that this PPI network with the involvement of
approximately 60% of the “complete” proteome repre-
sents the core of the human protein interactome.
Based on a global view of the way in which the
current network will have to expand to its maximum
potential in accordance with the scale-free theory, we
provide a novel perspective for suggesting its cur-
rently “missing” part. We envisage that the proteins
not yet identified in direct PPI assays may participate
in specialized biological functions interacting with a
limited number of other not well-connected proteins.
Now determined, this set of “orphan” proteins may
trigger targeted text mining efforts or appropriately
designed functional experiments for the identification
of any relevant PPIs. In effect, we suggest that this
reconstructed human interactome already provides a
Klapa et al. BMC Systems Biology 2013, 7:96 Page 13 of 14
http://www.biomedcentral.com/1752-0509/7/96useful tool for generating valuable working hypotheses
for the investigation of important biological processes
and molecular functions in the context of biomedical
research and applications.
Additional files
Additional file 1: The uploading process flowchart for the IntAct
PPI dataset using MS-SQL Integration Services (print screen shot).
Additional file 2: List of the 42 PPIs supported by 20 or more
references in the reconstructed network.
Additional file 3: The major annotation clusters of the 16 UniProt
identifiers with the largest number of PPIs. The UniProt identifier list
is provided in Table 3. The clusters were determined by the functional
annotation software DAVID using all relevant gene annotation
categorizations.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
NKM conceived and coordinated the study; MIK, AT and NKM participated in
the design of the study; MIK, KT and NKM selected the source datasets; MIK
supervised and KT created the dictionaries for the protein and publication
identifier updating; MIK and ET designed and validated the data uploading
process; ET developed the data uploading modules; MIK and NKM analyzed
the reconstructed network; MIK drafted and NKM finalized the manuscript.
All authors read and approved the final manuscript.
Acknowledgments
This work was supported by University of Patras and FORTH/ICE-HT internal
funds. Note: KT is currently a PhD candidate at the Novo Nordisk Foundation
Center for Protein Research, University of Copenhagen, Copenhagen,
Denmark; MIK holds an adjunct associate professorship at the Departments
of Chemical & Biomolecular Engineering and Bioengineering, University of
Maryland, College Park, MD 20742, USA.
Author details
1Metabolic Engineering and Systems Biology Laboratory, Institute of
Chemical Engineering Sciences, Foundation for Research and Technology-
Hellas (FORTH/ICE-HT), Rio, Patras, Greece. 2Department of General Biology,
School of Medicine, University of Patras, Rio, Patras, Greece. 3Computer
Engineering and Informatics Department, University of Patras, Rio, Patras,
Greece.
Received: 26 February 2013 Accepted: 25 September 2013
Published: 2 October 2013
References
1. Barabási AL, Gulbahce N, Loscalzo J: Network medicine: a network-based
approach to human disease. Nat Rev Genet 2011, 12:56–68.
2. Sharma A, Gulbahce N, Pevzner S, Menche J, Ladenvall C, Folkersen L,
Eriksson P, Orho-Melander M, Barabási AL: Network based analysis of
genome wide association data provides novel candidate genes for lipid
and lipoprotein traits. Mol Cell Proteomics 2013. Epub ahead of print.
3. Li S, Armstrong CM, Bertin N, Ge H, Milstein S, Boxem M, Vidalain PO, Han
JD, Chesneau A, Hao T, Goldberg DS, Li N, Martinez M, Rual JF, Lamesch P,
Xu L, Tewari M, Wong SL, Zhang LV, Berriz GF, Jacotot L, Vaglio P, Reboul J,
Hirozane-Kishikawa T, Li Q, Gabel HW, Elewa A, Baumgartner B, Rose DJ, Yu
H, Bosak S, Sequerra R, Fraser A, Mango SE, Saxton WM, Strome S, Van Den
Heuvel S, Piano F, Vandenhaute J, Sardet C, Gerstein M, Doucette-Stamm L,
Gunsalus KC, Harper JW, Cusick ME, Roth FP, Hill DE, Vidal M: A map of the
interactome network of the metazoan C. elegans. Sci 2004, 303:540–543.
4. Giot L, Bader JS, Brouwer C, Chaudhuri A, Kuang B, Li Y, Hao YL, Ooi CE,
Godwin B, Vitols E, Vijayadamodar G, Pochart P, Machineni H, Welsh M,
Kong Y, Zerhusen B, Malcolm R, Varrone Z, Collis A, Minto M, Burgess S,
McDaniel L, Stimpson E, Spriggs F, Williams J, Neurath K, Ioime N, Agee M,
Voss E, Furtak K, Renzulli R, Aanensen N, Carrolla S, Bickelhaupt E, LazovatskyY, DaSilva A, Zhong J, Stanyon CA, Finley RL Jr, White KP, Braverman M,
Jarvie T, Gold S, Leach M, Knight J, Shimkets RA, McKenna MP, Chant J,
Rothberg JM: A protein interaction map of Drosophila melanogaster.
Sci 2003, 302:1727–1736.
5. Gavin AC, Bösche M, Krause R, Grandi P, Marzioch M, Bauer A, Schultz J, Rick
JM, Michon AM, Cruciat CM, Remor M, Höfert C, Schelder M, Brajenovic M,
Ruffner H, Merino A, Klein K, Hudak M, Dickson D, Rudi T, Gnau V, Bauch A,
Bastuck S, Huhse B, Leutwein C, Heurtier MA, Copley RR, Edelmann A,
Querfurth E, Rybin V, Drewes G, Raida M, Bouwmeester T, Bork P, Seraphin
B, Kuster B, Neubauer G, Superti-Furga G: Functional organization of the
yeast proteome by systematic analysis of protein complexes. Nat 2002,
415:141–147.
6. Ito T, Ota K, Kubota H, Yamaguchi Y, Chiba T, Sakuraba K, Yoshida M: Roles
for the two-hybrid system in exploration of the yeast protein
interactome. Mol Cell Proteomics 2002, 1:561–566.
7. Uetz P, Giot L, Cagney G, Mansfield TA, Judson RS, Knight JR, Lockshon D,
Narayan V, Srinivasan M, Pochart P, Qureshi-Emili A, Li Y, Godwin B, Conover
D, Kalbfleisch T, Vijayadamodar G, Yang M, Johnston M, Fields S, Rothberg
JM: A comprehensive analysis of protein-protein interactions in
Saccharomyces cerevisiae. Nat 2000, 403:623–627.
8. Stelzl U, Worm U, Lalowski M, Haenig C, Brembeck FH, Goehler H,
Stroedicke M, Zenkner M, Schoenherr A, Koeppen S, Timm J, Mintzlaff S,
Abraham C, Bock N, Kietzmann S, Goedde A, Toksöz E, Droege A, Krobitsch
S, Korn B, Birchmeier W, Lehrach H, Wanker EE: A human protein-protein
interaction network: a resource for annotating the proteome. Cell 2005,
122:957–968.
9. Rual JF, Venkatesan K, Hao T, Hirozane-Kishikawa T, Dricot A, Li N, Berriz GF,
Gibbons FD, Dreze M, Ayivi-Guedehoussou N, Klitgord N, Simon C, Boxem
M, Milstein S, Rosenberg J, Goldberg DS, Zhang LV, Wong SL, Franklin G, Li
S, Albala JS, Lim J, Fraughton C, Llamosas E, Cevik S, Bex C, Lamesch P,
Sikorski RS, Vandenhaute J, Zoghbi HY, Smolyar A, Bosak S, Sequerra R,
Doucette-Stamm L, Cusick ME, Hill DE, Roth FP, Vidal M: Towards a
proteome-scale map of the human protein-protein interaction network.
Nat 2005, 437:1173–1178.
10. Orchard S, Kerrien S, Abbani S, Aranda B, Bhate J, Bidwell S, Bridge A,
Briganti L, Brinkman Fiona SL, Cesareni G, Chatr-aryamontri A, Chautard E,
Chen C, Dumousseau M, Goll J, Hancock Robert EW, Hannick LI, Jurisica I,
Khadake J, Lynn DJ, Mahadevan U, Perfetto L, Raghunath A, Ricard-Blum S,
Roechert B, Salwinski L, Stümpflen V, Tyers M, Uetz P, Xenarios I, Hermjakob
H: Protein interaction data curation: the International Molecular
Exchange (IMEx) consortium. Nat Methods 2012, 9:345–350.
11. Klingström T, Plewczynski D: Protein-protein interaction and pathway
databases, a graphical review. Brief Bioinform 2011, 12:702–713. Epub
2010 Sep 17.
12. Turinsky AL, Razick S, Turner B, Donaldson IM, Wodak SJ: Literature curation
of protein interactions: measuring agreement across major public
databases. Database (Oxford) 2010, 2010. 2010:baq026.
13. Cusick ME, Yu H, Smolyar A, Venkatesan K, Carvunis AR, Simonis N, Rual JF,
Borick H, Braun P, Dreze M, Vandenhaute J, Galli M, Yazaki J, Hill DE, Ecker
JR, Roth FP, Vidal M: Literature-curated protein interaction datasets.
Nat Methods 2009, 6:39–46.
14. Mathivanan S, Periaswamy B, Gandhi TK, Kandasamy K, Suresh S,
Mohmood R, Ramachandra YL, Pandey A: An evaluation of human
protein-protein interaction data in the public domain. BMC Bioinforma
2006, 7(Suppl 5):S19.
15. Kamburov A, Stelzl U, Lehrach H, Herwig R: The ConsensusPathDB
interaction database: 2013 update. Nucleic Acids Res 2013, 41(Database
issue):D793–D800.
16. Razick S, Magklaras G, Donaldson IM: iRefIndex: a consolidated protein
interaction database with provenance. BMC Bioinforma 2008, 9:405.
17. Prieto C, De Las RJ: APID: Agile Protein Interaction DataAnalyzer. Nucleic
Acids Res 2006, 34:W298–W302.
18. Schaefer MH, Fontaine JF, Vinayagam A, Porras P, Wanker EE, Andrade-
Navarro MA: HIPPIE: Integrating protein interaction networks with
experiment based quality scores. PLoS One 2012, 7:e31826.
19. Jayapandian M, Chapman A, Tarcea VG, Yu C, Elkiss A, Ianni A, Liu B, Nandi
A, Santos C, Andrews P, Athey B, States D, Jagadish HV: Michigan
molecular interactions r2: from interacting proteins to pathways. Nucleic
Acids Res 2009, 37(Database issue):D642–D646.
20. Das J, Yu H: HINT: High-quality protein interactomes and their
applications in understanding human disease. BMC Syst Biol 2012, 6:92.
Klapa et al. BMC Systems Biology 2013, 7:96 Page 14 of 14
http://www.biomedcentral.com/1752-0509/7/9621. Cowley MJ, Pinese M, Kassahn KS, Waddell N, Pearson JV, Grimmond SM,
Biankin AV, Hautaniemi S, Wu J: PINA v2.0: mining interactome modules.
Nucleic Acids Res 2012, 40(Database issue):D862–D865.
22. Chaurasia G, Malhotra S, Russ J, Schnoegl S, Hänig C, Wanker EE, Futschik
ME: UniHI 4: new tools for query, analysis and visualization of the human
protein-protein interactome. Nucleic Acids Res 2009, 37(Database issue):
D657–D660.
23. Cerami EG, Gross BE, Demir E, Rodchenkov I, Babur O, Anwar N, Schultz N,
Bader GD, Sander C: Pathway Commons, a web resource for biological
pathway data. Nucleic Acids Res 2011, 39(Database issue):D685–D690.
24. The UniProt Consortium: Reorganizing the protein space at the Universal
Protein Resource (UniProt). Nucleic Acids Res 2012, 40:D71–D75.
25. Keshava Prasad TS, Goel R, Kandasamy K, Keerthikumar S, Kumar S, Mathivanan S,
Telikicherla D, Raju R, Shafreen B, Venugopal A, Balakrishnan L, Marimuthu A,
Banerjee S, Somanathan DS, Sebastian A, Rani S, Ray S, Harrys Kishore CJ, Kanth S,
Ahmed M, Kashyap MK, Mohmood R, Ramachandra YL, Krishna V, Rahiman BA,
Mohan S, Ranganathan P, Ramabadran S, Chaerkady R, Pandey A: Human
Protein Reference Database--2009 update. Nucleic Acids Res 2009,
37(Database issue):D767–D772. Epub 2008 Nov 6.
26. Kerrien S, Aranda B, Breuza L, Bridge A, Broackes-Carter F, Chen C, Duesbury
M, Dumousseau M, Feuermann M, Hinz U, Jandrasits C, Jimenez RC,
Khadake J, Mahadevan U, Masson P, Pedruzzi I, Pfeiffenberger E, Porras P,
Raghunath A, Roechert B, Orchard S, Hermjakob H: The IntAct molecular
interaction database in 2012. Nucleic Acids Res 2011, 40(Database issue):
D841–D846. Epub 2011 Nov 24.
27. Licata L, Briganti L, Peluso D, Perfetto L, Iannuccelli M, Galeota E, Sacco F,
Palma A, Nardozza AP, Santonico E, Castagnoli L, Cesareni G: MINT, the
molecular interaction database: 2012 update. Nucleic Acids Res 2011,
40(Database issue):D857–D861. Epub 2011 Nov 16.
28. Salwinski L, Miller CS, Smith AJ, Pettit FK, Bowie JU, Eisenberg D: The
Database of Interacting Proteins: 2004 update. Nucleic Acids Res 2004,
32(Database issue):D449–D451.
29. Stark C, Breitkreutz BJ, Reguly T, Boucher L, Breitkreutz A, Tyers M:
Biogrid: A General Repository for Interaction Datasets. Nucleic Acids
Res 2006, 34:D535–D539.
30. Barabasi A-L, Oltvai ZN: Network biology: understanding the cell's
functional organization. Nat Rev Genet 2004, 5:101–113.
31. Huang DW, Sherman BT, Lempicki RA: Systematic and integrative analysis
of large gene lists using DAVID Bioinformatics Resources. Nature Protoc
2009, 4:44–57.
32. Huang DW, Sherman BT, Lempicki RA: Bioinformatics enrichment tools:
paths toward the comprehensive functional analysis of large gene lists.
Nucleic Acids Res 2009, 37:1–13.
33. Smoot M, Ono K, Ruscheinski J, Wang P-L, Ideker T: Cytoscape 2.8: new
features for data integration and network visualization. Bioinform 2011,
27:431–432.
34. Zhu Y, Zhang XF, Dai DQ, Wu MY: Identifying spurious interactions and
predicting missing interactions in the protein-protein interaction
networks via a generative network model. IEEE/ACM Trans Comput Biol
Bioinform 2013, 10:219–225.
35. Yu J, Finley RL Jr: Combining multiple positive training sets to generate
confidence scores for protein-protein interactions. Bioinform 2009,
25:105–111.
36. McDowall MD, Scott MS, Barton GJ: PIPs: human protein-protein interaction
prediction database. Nucleic Acids Res 2009, 37(Database issue):D651–D656.
37. Yook SH, Oltvai ZN, Barabási AL: Functional and topological characterization of
protein interaction networks. Proteomics 2004, 4:928–942.
38. Jonsson PF, Bates PA: Global topological features of cancer proteins in
the human interactome. Bioinform 2006, 22:2291–2297.
39. Ghersi D, Singh M: Disentangling function from topology to infer the
network properties of disease genes. BMC Syst Biol 2013, 7:5.
40. Vinayagam A, Stelzl U, Foulle R, Plassmann S, Zenkner M, Timm J, Assmus HE,
Andrade-Navarro MA, Wanker EE: A directed protein interaction network for
investigating intracellular signal transduction. Sci Signal 2011, 4:rs8.
41. Meek SE, Lane WS, Piwnica-Worms H: Comprehensive proteomic analysis
of interphase and mitotic 14-3-3-binding proteins. J Biol Chem 2004,
279:32046–32054.
42. Koch HB, Zhang R, Verdoodt B, Bailey A, Zhang CD, Yates JR 3rd, Menssen
A, Hermeking H: Large-scale identification of c-MYC-associated proteins
using a combined TAP/MudPIT approach. Cell Cycle 2007, 6:205–217.43. Bouwmeester T, Bauch A, Ruffner H, Angrand PO, Bergamini G, Croughton
K, Cruciat C, Eberhard D, Gagneur J, Ghidelli S, Hopf C, Huhse B, Mangano R,
Michon AM, Schirle M, Schlegl J, Schwab M, Stein MA, Bauer A, Casari G,
Drewes G, Gavin AC, Jackson DB, Joberty G, Neubauer G, Rick J, Kuster B,
Superti-Furga G: A physical and functional map of the human TNF-alpha
/NF-kappa B signal transduction pathway. Nat Cell Biol 2004, 6:97–105.
44. Venancio TM, Balaji S, Iyer LM, Aravind L: Reconstructing the ubiquitin
network: cross-talk with other systems and identification of novel
functions. Genome Biol 2009, 10:R33.
45. Du Y, Xu N, Lu M, Li T: hUbiquitome: a database of experimentally
verified ubiquitination cascades in humans. Database (Oxford) 2001,
2011. bar055.
46. Matsumoto M, Hatakeyama S, Oyamada K, Oda Y, Nishimura T, Nakayama KI:
Large-scale analysis of the human ubiquitin-related proteome. Proteomics
2005, 5:4145–4151.
47. Koutelou E, Sato S, Tomomori-Sato C, Florens L, Swanson SK, Washburn MP,
Kokkinaki M, Conaway RC, Conaway JW, Moschonas NK: Neuralized-like 1
(Neurl1) targeted to the plasma membrane by N-myristoylation
regulates the Notch ligand Jagged1. J Biol Chem 2008, 283:3846–3853.
doi:10.1186/1752-0509-7-96
Cite this article as: Klapa et al.: Reconstruction of the experimentally
supported human protein interactome: what can we learn?. BMC
Systems Biology 2013 7:96.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
